GCC Food Allergy Diagnosis Treatment Market

ID: MRFR/HC/51346-HCR

200 Pages

Rahul Gotadki

October 2025

GCC Food Allergy Diagnosis Treatment Market Research Report By Diagnosis Method (Skin Prick Test, Blood Test, Oral Food Challenge, Elimination Diet), By Treatment Type (Medication, Immunotherapy, Dietary Management, Emergency Treatment Devices), By End User (Hospitals, Clinics, Home Care, Pharmaceutical Companies) and By Age Group (Children, Adults, Elderly)- Forecast to 2035

GCC Food Allergy Diagnosis Treatment Market Infographic

Single User

Multiple License

Enterprise User

Summary Table of Contents Segmentation Download PDF

1. Market Overview

2. Market Trends

3. Market Segment Insights

4. Key Players and Competitive Insights

5. Industry Developments

6. Market Segmentation

7. Report Scope

8. Market Highlights

9. FAQs

Certified Researchers

Customize Report

GCC Food Allergy Diagnosis Treatment Market Summary

The GCC Food Allergy Diagnosis Treatment market is projected to grow significantly from 147.2 USD Million in 2024 to 310 USD Million by 2035.

Key Market Trends & Highlights

GCC Food Allergy Diagnosis Treatment Key Trends and Highlights

The market is expected to experience a compound annual growth rate (CAGR) of 7.01 percent from 2025 to 2035.
By 2035, the market valuation is anticipated to reach 310 USD Million, indicating robust growth potential.
In 2024, the market is valued at 147.2 USD Million, reflecting the increasing awareness of food allergies in the region.
Growing adoption of advanced diagnostic technologies due to rising incidences of food allergies is a major market driver.

GCC Food Allergy Diagnosis Treatment Market

CAGR

7.01%

Market Size & Forecast

2024 Market Size	147.2 (USD Million)
2035 Market Size	310 (USD Million)
CAGR (2025-2035)	7.01%

Major Players

Abbott Laboratories, Allergenis, Stallergenes Greer, Bayer, Horizon Therapeutics, Regeneron Pharmaceuticals, Eurofins Scientific, Thermo Fisher Scientific, AstraZeneca, Nestle, Greenspace, Aimmune Therapeutics, Mylan, Danone, ImmunoTechnology

GCC Food Allergy Diagnosis Treatment Market Trends

The GCC Food Allergy Diagnosis Treatment Market is witnessing significant trends driven by various factors within the region. An increase in food allergies, particularly among children, has led to a heightened awareness and demand for accurate diagnosis and effective treatment options. Government initiatives across GCC nations emphasize the importance of health and wellness, encouraging research and development in allergy diagnostics and treatment modalities. This focus on improving healthcare services not only reflects a growing understanding of food allergies but also a commitment to better healthcare outcomes for the population.

Opportunities in the market are being created by advancements in technology and increased accessibility to diagnostic tools.The rise of telemedicine also provides new avenues for patients to consult healthcare professionals regarding food allergies, allowing for quicker diagnosis and treatment plans. There is a potential to develop customized treatment solutions that cater specifically to the dietary needs and preferences of the GCC's diverse population, which can improve patient compliance and satisfaction. Recent trends include the introduction of more innovative diagnostic methods such as skin prick tests and blood tests that are quick and more reliable.

Along with this, the growth of allergen-free food alternatives in the region is also becoming prominent, reflecting consumer demand for safer food options.The awareness campaigns led by health authorities in GCC countries aim to educate the public on food allergy management, further influencing market growth. These developments point towards a dynamic and responsive market structure in the GCC, shaped by its cultural and health landscape.

Market Segment Insights

GCC Food Allergy Diagnosis Treatment Market Segment Insights

Food Allergy Diagnosis Treatment Market Diagnosis Method Insights

The Diagnosis Method segment of the GCC Food Allergy Diagnosis Treatment Market showcases a variety of approaches vital for effective allergy detection and management. The Skin Prick Test stands out as a widely used method, characterized by its efficiency and cost-effectiveness, enabling quick results that can guide clinical decisions. This technique involves introducing a small amount of allergen into the skin and observing for allergic reactions, making it essential in determining specific sensitivities. Alongside this, the Blood Test has gained popularity as a reliable alternative, particularly in cases where patients may have difficulty with skin testing.

It quantifies allergen-specific immunoglobulin E (IgE) levels, providing a comprehensive view of an individual’s allergy profile.

The Oral Food Challenge represents a critical gold standard in allergy diagnosis. This method involves administering gradual amounts of suspected allergens to determine the likelihood of a food allergy, allowing for a definitive diagnosis. Its significance lies in its ability to confirm allergies that may not be evident through other testing methods. The Elimination Diet, on the other hand, plays a pivotal role in managing food allergies. This approach involves removing potential allergens from the diet and gradually reintroducing them to identify specific triggers, thus requiring close monitoring and evaluation by healthcare professionals.

Each method, while having its own processes and applications, is interconnected within the holistic framework of the GCC Food Allergy Diagnosis Treatment Market, addressing the growing concern of food allergies in the region. The increased prevalence of food allergies in GCC countries is driving demand for accurate and reliable diagnosis methods, fostering a deeper understanding of allergies and paving the way for advancements in treatment options. As awareness grows regarding food allergies, these diagnostic techniques become increasingly important in ensuring patient safety and improving quality of life.

Food Allergy Diagnosis Treatment Market Treatment Type Insights

The Treatment Type segment of the GCC Food Allergy Diagnosis Treatment Market emphasizes various approaches to manage food allergies effectively. Medication plays a crucial role, offering symptomatic relief through antihistamines and corticosteroids, which cater to the growing need for immediate and accessible solutions. Immunotherapy is gaining traction as an innovative long-term treatment option, enhancing tolerance to allergens and significantly improving patient quality of life, thus reflecting robust market interest. Dietary Management emphasizes personalized nutrition plans tailored to individual needs, highlighting the importance of education and lifestyle adjustments in preventing allergic reactions.

Emergency Treatment Devices, such as auto-injectors, ensure rapid response during anaphylactic incidents, demonstrating their essential role in safeguarding patients. This diverse spectrum within the Treatment Type segment is driven by increasing allergy prevalence in the GCC region, rising awareness about food allergies, and advancements in treatment modalities, indicating substantial growth opportunities aligned with evolving healthcare policies and consumer demand in the region.

Food Allergy Diagnosis Treatment Market End User Insights

The ser segment of the GCC Food Allergy Diagnosis Treatment Market plays a crucial role in determining the efficiency of diagnosis and treatment options available to patients. Hospitals are often at the forefront, providing advanced diagnostic tools and treatment therapies, catering to a significant portion of the population suffering from food allergies. Clinics serve as accessible care points, offering immediate support and specialized services for individuals, thus enhancing the market's reach among urban and rural communities. Home Care has gained traction due to its convenience and personalized treatment plans, catering especially to those requiring ongoing monitoring and support.

Pharmaceutical Companies contribute significantly by developing innovative treatments and allergy management solutions, ensuring the availability of effective medications in the region. The awareness regarding food allergies is on the rise in the GCC, propelled by government initiatives aimed at promoting health and wellness throughout the community. This increase in awareness, combined with effective healthcare delivery across various End Users, helps drive the overall market's growth. Furthermore, the demand for comprehensive management strategies for food allergies fosters collaboration among these key End Users, facilitating a holistic approach to managing food allergies in the GCC population.

Food Allergy Diagnosis Treatment Market Age Group Insights

In the GCC Food Allergy Diagnosis Treatment Market, the Age Group segmentation includes Children, Adults, and the Elderly, each with unique dynamics. Children represent a critical segment due to the alarming rise in food allergies among this demographic, driven by increased exposure to allergenic foods and environmental factors. This has led to a growing demand for specialized diagnosis and treatment options tailored for pediatric care, which is often viewed as the cornerstone for long-term allergy management.

Adults often contend with life-changing impacts of food allergies as they navigate dietary restrictions and lifestyle modifications, emphasizing the need for effective diagnostic tools and therapeutic interventions.

The Elderly population, while smaller in number, presents distinct challenges that arise from concurrent health issues, necessitating comprehensive care strategies that address food allergies alongside other medical conditions. In the GCC region, rising awareness regarding food allergies, combined with government initiatives aimed at improving public health, create opportunities for innovative solutions in allergy diagnosis and treatment across all age groups, thereby driving the overall growth of the GCC Food Allergy Diagnosis Treatment Market.The evolving landscape underscores an urgent demand for tailored services and products that enhance quality of life for individuals at every stage of life.

Get more detailed insights about GCC Food Allergy Diagnosis Treatment Market Research Report - Forecast to 2035

Request Free Sample

Key Players and Competitive Insights

The GCC Food Allergy Diagnosis Treatment Market is an evolving landscape marked by increasing awareness regarding food allergies among consumers, healthcare professionals, and regulatory bodies. The market is characterized by a mix of multinational corporations and local startups striving to offer innovative solutions for the diagnosis and treatment of food allergies. As the prevalence of food allergies rises, particularly among children, there is a growing demand for high-quality testing methods and treatment options.

Competitive insights reveal that companies are investing heavily in research and development to enhance their product portfolios, focusing on precision and accuracy in diagnostics as well as developing effective therapies. Collaborations and partnerships are increasingly common, as firms seek to expand their reach and enhance their capabilities in this niche sector.Abbott Laboratories holds a significant position in the GCC Food Allergy Diagnosis Treatment Market, driven by its commitment to advancing health outcomes through innovative technology.

The company's strengths lie in its robust portfolio of diagnostic solutions that facilitate the accurate identification of food allergies, thereby supporting timely and effective treatment options.

Abbott's global experience and established presence in the GCC region allow it to leverage local knowledge and expertise, providing tailored products that cater to the dietary preferences and health concerns of the local population. This local presence, combined with a reputation for quality and reliability in diagnostics, positions Abbott Laboratories as a formidable competitor in the market.Allergenis is another key player within the GCC Food Allergy Diagnosis Treatment Market, distinguished by its focus on specific allergy testing and immunotherapy solutions.

Known for its commitment to delivering precise and actionable results, Allergenis offers a range of services that are designed to meet the needs of patients and healthcare providers alike.

The company has developed a strong portfolio of products including allergy tests that help in the effective diagnosis of food allergies. Additionally, Allergenis has engaged in strategic mergers and acquisitions to strengthen its market presence and expand its capabilities within the GCC. This strategic approach not only enhances its service offerings but also reinforces its competitive edge by positioning the company as a leader in the allergy diagnostic field through advanced technology and localized services tailored to meet the specific needs of patients in the region.

Key Companies in the GCC Food Allergy Diagnosis Treatment Market market include

Industry Developments

The GCC Food Allergy Diagnosis Treatment Market has recently seen significant developments, particularly in the realm of technological innovations and product launches. In September 2023, Nestle introduced a new line of food products designed specifically for individuals with food allergies, aiming to provide safer dietary options. Moreover, the market has experienced considerable growth; the market size is expected to expand significantly due to increasing awareness of food allergies and rising disposable incomes in the region, which allows for more investments in healthcare solutions.

In terms of mergers and acquisitions, Abbott Laboratories has been actively acquiring small biotech firms to enhance its diagnostic capabilities, with reports confirming this activity in August 2023 following their strategy shift towards a more diversified healthcare portfolio. Companies like Regeneron Pharmaceuticals and AstraZeneca have also reported advancements in Research and Development activities aimed at addressing food allergies, bolstering their presence in this growing market.

Overall, the GCC Food Allergy Diagnosis Treatment Market is progressing rapidly, driven by increased consumer demand for specialized treatments and innovative therapies, establishing the region as a key player in the global landscape.

Market Segmentation

Outlook

Children
Adults
Elderly

Report Scope

Report Attribute/Metric Source:	Details
MARKET SIZE 2023	147.2(USD Million)
MARKET SIZE 2024	156.2(USD Million)
MARKET SIZE 2035	310.0(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)	6.429% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Million
KEY COMPANIES PROFILED	Abbott Laboratories, Allergenis, Stallergenes Greer, Bayer, Horizon Therapeutics, Regeneron Pharmaceuticals, Eurofins Scientific, Thermo Fisher Scientific, AstraZeneca, Nestle, Greenspace, Aimmune Therapeutics, Mylan, Danone, ImmunoTechnology
SEGMENTS COVERED	Diagnosis Method, Treatment Type, End User, Age Group
KEY MARKET OPPORTUNITIES	Increased prevalence of food allergies, Growing demand for rapid testing, Advancements in diagnostic technologies, Rising awareness and education initiatives, Expansion of personalized treatment options
KEY MARKET DYNAMICS	rising prevalence of food allergies, increasing awareness among clinicians, advancements in diagnostic technologies, improved treatment options, growing consumer demand for safety
COUNTRIES COVERED	GCC

FAQs

What is the expected market size of the GCC Food Allergy Diagnosis Treatment Market by 2024?

The GCC Food Allergy Diagnosis Treatment Market is expected to be valued at 156.2 million USD by 2024.

What is the projected market value of the GCC Food Allergy Diagnosis Treatment Market by 2035?

By 2035, the market is projected to reach 310.0 million USD.

What is the expected CAGR for the GCC Food Allergy Diagnosis Treatment Market from 2025 to 2035?

The GCC Food Allergy Diagnosis Treatment Market is anticipated to grow at a CAGR of 6.429% during the forecast period from 2025 to 2035.

Which diagnosis method is expected to hold the largest market share in 2024?

The Skin Prick Test is anticipated to hold the largest market share, valued at 45.0 million USD in 2024.

What is the expected market size for the Blood Test method in the GCC Food Allergy Diagnosis Treatment Market by 2035?

The Blood Test method is expected to grow to 80.0 million USD by 2035.

Who are the major players in the GCC Food Allergy Diagnosis Treatment Market?

Major players in the market include Abbott Laboratories, Stallergenes Greer, Bayer, and Horizon Therapeutics among others.

What is the market value for the Oral Food Challenge method in 2024?

The Oral Food Challenge method is valued at 30.0 million USD in the year 2024.

What opportunities exist in the GCC Food Allergy Diagnosis Treatment Market?

The market offers opportunities for growth driven by advancements in diagnostic techniques and increasing awareness of food allergies.

What are the expected growth figures for the Elimination Diet method from 2024 to 2035?

The Elimination Diet method is expected to grow from 41.2 million USD in 2024 to 78.0 million USD by 2035.

How is the GCC Food Allergy Diagnosis Treatment Market projected to evolve in the coming years?

The market is projected to evolve positively, driven by rising prevalence of food allergies and improved diagnostic solutions.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Chemicals and Materials

Global Magnesium Sulfate Market – Forecast till 2027